All News

Hospitals & Health Systems Report: There were fewer, but larger, hospital mergers and acquisitions in 2018

by Tina Reed | Jan 15, 2019 The number of hospital mergers last year dipped about 22% in 2018 but grew in overall size as part of a broader trend toward megamergers, according to a new report. In all, hospitals announced a total of 90 transactions in 2018, down from 115 in 2017, according to a report (PDF) from Kaufman Hall. The firm began monitoring …

Additive Orthopaedics Announces FDA Clearance of their Patient Specific 3D Printed Locking Lattice Plates for the Global Extremities Market

LITTLE SILVER, N.J., Jan. 14, 2019 /PRNewswire/ — Additive Orthopaedics, LLC., the leader in 3D printed orthopaedic foot and ankle devices, announces that is has received FDA 510(k) clearance for its Patient Specific 3D Printed Locking Lattice Plates indicated for alignment, stabilization and fusion of fractures, osteotomies and arthrodesis of small bones such as the foot and …

Leading Sports Medicine Doctor Accelerates Diagnosis and Enhances Patient Experience With The SONON 300L Portable Wireless Ultrasound

ROSEVILLE, Calif., Jan. 15, 2019 /PRNewswire/ — Healcerion today announced that one of the top doctors in sports medicine Dr. Vijay Vad chose to use SONON 300L to accelerate patient diagnostic process while improving patient relationships through deeper insight and high quality real-time image sharing, conveniently located in his pocket. Dr. Benjamin Ryu, CEO and Founder of Healcerion, says, “We are pleased with …

Bioventus Launches OSTEOMATRIX+® Biphasic Bone Graft

January 15, 2019 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, is launching OSTEOMATRIX+, its next generation biphasic bone graft for use in bone remodeling in a variety of orthopaedic and spine applications. OSTEOMATRIX+ is a moldable bone graft substitute consisting of bovine collagen and biphasic, hydroxyapatite/ß-tricalcium phosphate granules designed to produce a reliable, porous scaffold and sustained …

Lipogems Provides Orthopaedic Patients With Another Option To Major Invasive Surgery

ATLANTA, Jan. 14, 2019 /PRNewswire/ — The Lipogems system is leading the way in reparative medicine by providing patients another option to major, invasive surgery. With FDA clearance, strong scientific evidence and teams of scientists and physicians, the Lipogems system may help thousands currently struggling with orthopaedic conditions who have tried conservative options like physical therapy, injections and pain …

Uniontown surgery center certified for outpatient knee replacements

Jan 14, 2019 / By Rachel Basinger After a nearly two-year application process with the Pennsylvania Department of Health, Elite Surgery Center in Uniontown is now one of just four centers in the entire state that has been granted exceptions to perform outpatient knee replacement surgeries. “Our patients want to have this option,” said Dr. …

Spinal Elements Announces New Chairman of the Board

January 14, 2019 CARLSBAD, Calif.–(BUSINESS WIRE)–Spinal Elements, a Carlsbad, California-based spine technology company, today announced that spine industry veteran Steve Healy has been named Chairman of the Board of Directors, effective as of January 1, 2019. Mr. Healy joined Spinal Elements’ board in May 2018. Steve Healy brings a wealth of experience to Spinal Elements. …

InVivo Therapeutics Announces Richard Christopher as CFO and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 14, 2019  CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq:NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries (SCIs), today announces the appointment of Richard Christopher as its Chief Financial Officer and Treasurer, effective January 14, 2019. Prior to joining InVivo, Mr. Christopher was the Chief Financial …

Trice Medical Closes $18.3 Million Series C Extension

January 14, 2019 MALVERN, Pa.–(BUSINESS WIRE)–Trice Medical announced today that it closed an $18.3 million Series C Extension financing round. The company will use the proceeds to expand their worldwide commercialization efforts for mi-eye 2™ and mi-ultra™ and to accelerate the development of their minimally invasive product portfolio. This round was led by Charter Capital Partners of Grand …

Trice Medical Closes $18.3 Million Series C Extension

January 14, 2019 MALVERN, Pa.–(BUSINESS WIRE)–Trice Medical announced today that it closed an $18.3 million Series C Extension financing round. The company will use the proceeds to expand their worldwide commercialization efforts for mi-eye 2™ and mi-ultra™ and to accelerate the development of their minimally invasive product portfolio. This round was led by Charter Capital Partners of Grand …

© 2019 MedDeviceJobs.com Powered by Careerleaf
v.3.1.2